Literature DB >> 2299988

Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography.

S Jiao1, T G Cole, R T Kitchens, B Pfleger, G Schonfeld.   

Abstract

To assess genetic variation of murine lipoprotein profiles, plasma lipoproteins of 11 inbred strains, AKR/J, BALB/cByJ, C3H/HeJ, C57BL/6J, C57BL/6ByJ, C57L/J, DBA/1LacJ, 129/J, NZB/B1NJ, PL/J, and SWR/J, were analyzed by gel-permeation chromatography (fast peptide liquid chromatography) and nondenaturing gradient gel electrophoresis. Vena caval blood was drawn after 18 to 20 hours of fasting. Plasma triglyceride and cholesterol concentrations ranged from 12.9 mg/dL (C57BL/6ByJ) to 66.9 mg/dL (C3H/HeJ) and from 54.8 mg/dL (AKR/J) to 128.5 mg/dL (NZB/B1NJ), respectively. Mouse strain-related heterogeneities of very low-, low-, and high-density lipoprotein (VLDL, LDL, and HDL, respectively) concentrations were documented; VLDL-triglyceride concentrations ranged from 7.5 mg/dL to 38.8 mg/dL, LDL cholesterol from 12.0 mg/dL to 39.6 mg/dL, and HDL cholesterol from 41.3 mg/dL to 92.4 mg/dL. Hyper-VLDL-triglyceridemia was present in C3H/HeJ and SWR/J strains and hyper-LDL-cholesterolemia in NZB/B1NJ, C3H/HeJ, and DBA/1LacJ. VLDL cholesterol/VLDL triglyceride ratios also ranged widely among strains (0.13 to 0.43), with C57BL/6J, C57BL/6ByJ, and C57L/J, the strains particularly susceptible to diet-induced atherosclerosis, having the highest VLDL-lipid ratio. LDL and HDL size heterogeneities were also observed. LDL and HDL diameters ranged between 24.1 nm and 29.4 nm, and between 9.24 nm and 10.32 nm, respectively. Although LDL sizes showed no segregation, HDL sizes fell into two groups. C57L/J and C57BL/6J possessed low HDL-cholesterol concentrations and small-sized HDL. HDL sizes were positively correlated with HDL-cholesterol concentrations (r = .90, P less than .001) and LDL-cholesterol concentrations (r = .85, P less than .001), but LDL sizes did not correlate with lipoprotein concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299988     DOI: 10.1016/0026-0495(90)90069-o

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  38 in total

1.  FoxO transcription factors are required for hepatic HDL cholesterol clearance.

Authors:  Samuel X Lee; Markus Heine; Christian Schlein; Rajasekhar Ramakrishnan; Jing Liu; Gabriella Belnavis; Ido Haimi; Alexander W Fischer; Henry N Ginsberg; Joerg Heeren; Franz Rinninger; Rebecca A Haeusler
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

2.  A comparison of the mouse and human lipoproteome: suitability of the mouse model for studies of human lipoproteins.

Authors:  Scott M Gordon; Hailong Li; Xiaoting Zhu; Amy S Shah; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2015-04-27       Impact factor: 4.466

3.  Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA.

Authors:  Ruud S Kootte; Loek P Smits; Fleur M van der Valk; Jean-Louis Dasseux; Constance H Keyserling; Ronald Barbaras; John F Paolini; Raul D Santos; Theo H van Dijk; Geesje M Dallinga-van Thie; Aart J Nederveen; Willem J M Mulder; G Kees Hovingh; John J P Kastelein; Albert K Groen; Erik S Stroes
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

Review 4.  Dietary restriction in rats and mice: a meta-analysis and review of the evidence for genotype-dependent effects on lifespan.

Authors:  William R Swindell
Journal:  Ageing Res Rev       Date:  2011-12-23       Impact factor: 10.895

5.  Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.

Authors:  J M Hoeg; S Santamarina-Fojo; A M Bérard; J F Cornhill; E E Herderick; S H Feldman; C C Haudenschild; B L Vaisman; R F Hoyt; S J Demosky; R D Kauffman; C M Hazel; S M Marcovina; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes.

Authors:  L S Huang; E Voyiaziakis; D F Markenson; K A Sokol; T Hayek; J L Breslow
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.

Authors:  T Chajek-Shaul; T Hayek; A Walsh; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

8.  Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.

Authors:  M E Brousseau; S Santamarina-Fojo; L A Zech; A M Bérard; B L Vaisman; S M Meyn; D Powell; H B Brewer; J M Hoeg
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

9.  Atherosclerosis and plasma and liver lipids in nine inbred strains of mice.

Authors:  P M Nishina; J Wang; W Toyofuku; F A Kuypers; B Y Ishida; B Paigen
Journal:  Lipids       Date:  1993-07       Impact factor: 1.880

10.  Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver.

Authors:  Eliete J B Bighetti; Patrícia R Patrício; Andrea C Casquero; Jairo A Berti; Helena C F Oliveira
Journal:  Lipids Health Dis       Date:  2009-11-23       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.